Adult Immunization
Latest News
Jun 23, 2026 | News
Social Determinants May Improve Disease Risk Prediction Beyond Genetics Alone
FDA Issues CRL to Cytisinicline for Smoking Cessation
Jun 22, 2026
Home Sleep Testing for GLP-1 Coverage Shows Modest Diagnostic Yield in New Study
Jun 19, 2026
FDA Expands Teplizumab Approval for Pediatric Stage 3 Type 1 Diabetes
Jun 18, 2026
Reishi Mushroom Extract Outperformed Melatonin for Chronic Insomnia in New Study
Jun 17, 2026
Advertisement
Shorts
0:45
5 Colorectal Cancer Warning Signs to Watch For
13 days ago
by
Xavier Llor, MD, PhD
0:43
Why Hypertension Treatment is Failing Half of Patients
14 days ago
by
Payal Kohli, MD, FACC
0:25
Where Baxdrostat Fits in the Hypertension Treatment Pathway
a month ago
by
Payal Kohli, MD, FACC
1:37
Why Baxdrostat is the GOAT of Blood Pressure Medications
a month ago
by
Payal Kohli, MD, FACC
0:38
The Hidden Risk: Pregnancy-Related Deaths After Birth
a month ago
by
David Goodman, PhD
0:56
What Evidence is Still Needed in Major Depressive Disorder Treatment?
a month ago
by
Leslie Citrome, MD
0:41
A New Era in Vasomotor Symptom Treatment
a month ago
by
Jill Liss, MD
0:53
Adjunctive MDD Therapy: “The Right Drug to the Right Person”
a month ago
by
Leslie Citrome, MD
0:52
How PCPs Can Manage Menopause Conversations in a 15-Minute Visit
a month ago
by
Jill Liss, MD
0:27
MDD Treatment: When Antidepressants Aren’t Enough
a month ago
by
Leslie Citrome, MD
Nephrology Condition Center Quiz
As a part of efforts to develop further educational resources on chronic kidney disease (CKD) we are asking you to take this short quiz. From your response we will be able to see where there are gaps in knowledge and we can work to fill those gaps.
Exclusive Survey Results: Screening For Cognitive Decline in Primary Care
New survey finds that most PCPs screen for mild cognitive impairment, but time is an issue, guidelines are few, and low levels of confidence persist.
2025 Postoperative Pain Management: Progress and Process
Latest Videos
All News
Advertisement
Advertisement
High-risk rural patients were less likely than urban patients to be referred for obstructive sleep apnea evaluation in primary care.
New research suggests EDS combined with prolonged sleep-onset latency is linked to 3x greater risk of incident hypertension and 2x greater risk of prevalent hypertension.
The EEG-guided MeRT system is the first personalized, biomarker-guided neuromodulation technology to receive FDA clearance for PTSD.
AD109 Reduces OSA Severity in Phase 3 Trial of CPAP-Intolerant Adults
Published: | Updated:
AD109 reduced apnea-hypopnea index versus placebo in a phase 3 trial of adults with OSA unable or unwilling to use CPAP.
Takeda reported phase 3 data showing zasocitinib achieved higher week 16 PASI 100 responses than deucravacitinib in plaque psoriasis.
Late-breaking SLEEP 2026 findings bring primary-care-ready insights on insomnia drugs, sleep apnea genetics, menopausal sleep, and GLP-1 links.
SLEEP 2026: Women with moderate-to-severe obstructive sleep apnea reported worse sleep, fatigue, anxiety, headaches, and nocturia than men.
The first guideline for cardiovascular-kidney-metabolic syndrome details staging, screening, risk assessment, and treatment.
Retatrutide phase 3 trials showed reductions in weight, A1C, osteoarthritis pain, and sleep apnea severity.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Issues CRL to Cytisinicline for Smoking Cessation
2
Home Sleep Testing for GLP-1 Coverage Shows Modest Diagnostic Yield in New Study
3
Social Determinants May Improve Disease Risk Prediction Beyond Genetics Alone
4
Practical Sleep Hygiene Counseling for Cardiovascular Risk Reduction in Primary Care
5